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Abstract 
Motivation: CRISPR-Cas9 loss-of-function pooled screening promises to identify which long noncod-
ing RNAs (lncRNAs), amongst the many thousands to have been annotated so far, are capable of 
mediating cellular functions. The two principal loss-of-function perturbations, CRISPR-inhibition and 
CRISPR-deletion, employ one and two guide RNAs, respectively. However, no software solution has 
the versatility to identify hits across both modalities, and the optimal design parameters for such 
screens remain poorly understood. 
Results: Here we present CASPR (CRISPR Analysis for Single and Paired RNA-guides), a user-
friendly, end-to-end screen analysis tool. CASPR is compatible with both CRISPRi and CRISPR-del 
screens, and balances sensitivity and specificity by generating consensus predictions from multiple 
algorithms. Benchmarking on ground-truth sets of cancer-associated lncRNAs demonstrates CASPR’s 
improved sensitivity with respect to existing methods. Applying CASPR to published screens, we iden-
tify two parameters that predict lncRNA hits: expression, and annotation quality of the transcription start 
site. Thus CASPR is a versatile and complete solution for lncRNA CRISPR screen analysis, and reveals 
principles for including lncRNAs in screening libraries. 
Availability: https://judithbergada.github.io/CASPR/ 
Contact: Rory Johnson rory.johnson@dbmr.unibe.ch 
Supplementary information: Supplementary data are available at Bioinformatics online. 
 
1 Introduction  
CRISPR-Cas9 genome-engineering has been a breakthrough technology 
by enabling functional screening of non-protein-coding elements. Fore-
most amongst these are the long noncoding RNAs (lncRNAs), which are 
challenging to perturb using classical RNA interference (RNAi) technol-
ogy(Stojic et al., 2018). Deployment of CRISPR in high-throughput 
pooled screening format promises to discover functional and disease-re-
lated genes amongst the tens of thousands of lncRNA gene loci in the 
latest annotations(Esposito et al., 2019). 
 
Perturbation of lncRNAs requires distinct experimental design compared 
to protein-coding genes (PCGs). The latter require one single Cas9 pro-
tein, targeted by an engineered single guide RNA (sgRNA), to induce an 
indel mutation in the open reading frame (ORF) and achieve a complete 
loss-of-function (LOF) frameshift mutation (Esposito et al., 2019). In 
contrast, lncRNAs have, by definition, no ORF. Thus, two principal LOF 
approaches have been applied (Figure 1A). First, CRISPR-inhibition 
(CRISPRi), where transcriptional repression is achieved by an enzymati-
cally dead Cas9 (dCas9) fused to a repressor domain, such as KRAB(Liu 
et al., 2017). Second, CRISPR-deletion (CRISPR-del), where a pair of  
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Figure 1. A. CRISPR loss-of-function perturbations. In CRISPR-inhibition (CRISPRi), a single sgRNA is used to recruit a chimaeric protein composed of an effector domain (such as 
KRAB) fused to a catalytically-dead Cas9 (dCas9), and reversibly inhibits transcription of the target gene. In CRISPR-deletion (CRISPR-del), a pair of sgRNAs (pgRNA) recruit wild-type 
Cas9 endonucleases to sites flanking the target region (here, the gene’s transcription start site), creating a genomic deletion and silencing gene expression. B. sgRNAs can be uniquely 
identified by sequencing their 20 nt protospacer region. For sgRNA libraries, forward reads that contain the 20 nt protospacers are sufficient. For pgRNA libraries, forward and reverse reads 
are needed. C. The CASPR pipeline. As inputs it requires the sequencing reads, a design library of sgRNA protospacers, and an experimental design file defining the treatment and control 
samples. Then, it performs the quality control and trimming of reads, as well as the indexing of the sgRNA library. CASPR later maps the reads to the guides and provides a count table, 
which is used to identify gene hits by two different algorithms, MAGeCK and PBNPA. D. Scheme for indexing the library. Protospacers are converted to FASTA format and indexed with 
STAR. For pgRNA libraries, CASPR concatenates the two protospacers. E. Read trimming of raw sequencing reads to extract protospacer sequences. Resulting FASTQ file will be mapped 
to the indexed library. 
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Cas9 complexes is used to induce simultaneous breaks flanking the 
lncRNA and thereby delete it (Aparicio-Prat et al., 2015). CRISPRi is 
transient and requires one sgRNA; CRISPR-del is permanent and requires 
two sgRNAs, sometimes referred to as paired guide RNAs (pgRNAs). 
  
In pooled CRISPR screens, functional lncRNAs are identified by the en-
richment or depletion of their targeting sgRNAs between two or more 
populations of phenotypically distinct cells (Esposito et al., 2019). Multi-
ple unique sgRNA constructs are used for every target, and replicated ex-
periments performed, in order to identify hits against a background of 
technical and biological noise. At the end of experiments, genomically-
inserted sgRNA sequences are amplified by PCR and sequenced by next 
generation sequencing (NGS) (Figure 1B). The unique 20mer proto-
spacer(s) in each sgRNA or pair of sgRNAs, are used as molecular bar-
codes to track the frequency of each knockout cell population. A growing 
number of software packages have been created to identify hits from such 
screens, based on a variety of statistical approaches. These packages may 
either take as input the raw sequencing reads and provide an “end-to-end” 
analysis (such as PinAPL-Py and MAGeCK) (Spahn et al., 2017; Li et al., 
2014), or just accept count tables of already processed reads (such as 
BAGEL, STARS and PBNPA)(Hart and Moffat, 2016; Doench et al., 
2016; Jia et al., 2017). 
  
Effective sgRNA library design is critical for the success of lncRNA 
CRISPR screens. Both CRISPRi and CRISPR-del experiments require the 
targeting of Cas9 complexes within narrow genomic window of <1 kb 
around the TSS (Sanson et al., 2018). CRISPR-del studies can delete the 
lncRNA’s promoter and TSS, rather than the whole gene, to minimise off-
target effects and maximise deletion efficiency (Aparicio-Prat et al., 
2015), although the single available CRISPR-del screen incorporated a 
mixture of TSS and whole-gene deletions (Zhu et al., 2016). In contrast 
to PCGs, lncRNA gene catalogues are growing rapidly, their accuracy is 
poor (particularly in correctly annotating the transcription start site 
(TSS)), and publicly-available screening libraries are highly incomplete 
(Uszczynska-Ratajczak et al., 2018). Thus lncRNA screens are at risk of 
high false negative rates arising from poor annotations. 
  
Although growing numbers of screens are being performed on lncRNAs 
and other non-coding elements (Gasperini et al., 2017; Diao et al., 2017; 
Zhu et al., 2016), key resources are lacking. First, no analysis pipeline is 
capable of handling both single and paired sgRNA experiments. Second, 
we lack an understanding of the rules by which lncRNAs should be judged 
as good candidates for inclusion in a screen (Liu et al., 2017). In the pre-
sent study we address these issues through the creation of a new CRISPR 
screen analysis pipeline capable of perturbation-independent, end-to-end 
analysis. We deploy this pipeline on recently-published screen data to bet-
ter understand the behaviour of such screens and establish guidelines for 
design of future screens. 
2 Methods 
CASPR pipeline: The CASPR pipeline is programmed in Bash. It is 
based on five subprograms following the workflow presented in Figure 
1C, each of which can be run independently. CASPR is available at 
https://judithbergada.github.io/CASPR/, with documentation and instruc-
tions. 
Indexing: The library of single or paired sgRNAs must be provided as a 
text file with three or four columns, respectively: IDs, target gene names, 
and 20 nt protospacer sequences. CASPR transforms the library into a 
FASTA file. Importantly, for pgRNAs, this FASTA file concatenates sec-
ond and first protospacer sequences, in that order (Figures 1D). The li-
brary FASTA file is indexed using STAR (Dobin et al., 2013). 
 
Quality control of the reads: Read qualities are tested by FastQC and 
outputs are stored for inspection (http://www.bioinformatics.babra-
ham.ac.uk/projects/fastqc/). 
 
Trimming: Sequencing reads (FASTQ files) are trimmed with cutadapt 
(EMBnet., 1994) based on adapters that are either specified by the users 
or set by default. Cutadapt identifies the 5’ position of the adapters and 
removes all nucleotides upstream and downstream of the protospacers 
(Figure 1E). Reads are rejected if the adapter is not found or the sequence 
of the remaining protospacer is shorter than 5bp. To handle pgRNA li-
braries, two protospacers must be sequenced using forward and reverse 
reads (Figure 1B). Thus, their sequences can be extracted separately as 
described above. CASPR computes then the reverse-complement of the 
second protospacer by employing the fastx_reverse_complement function 
available at FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/), 
and concatenates the resulting paired sgRNAs to create a new FASTQ file 
(Figure 1D). To account for situations in which adapters are not se-
quenced, CASPR checks if they are placed at the same coordinates in 
more than 25% of the reads. Otherwise, protospacers are assumed to start 
at the first 5’ base-pair. 
 
Mapping: Trimmed reads are mapped to the indexed guide-RNAs using 
STAR (Dobin et al., 2013). CASPR allows users to tune mapping param-
eters, in terms of mismatches and minimum number of matched nucleo-
tides. Reads that map to >1 library sequence are discarded to avoid con-
founding effects. In contrast to other software, CASPR affords flexibility 
during the mapping step, while providing a proper quantification for both 
sgRNA and pgRNA libraries.  
 
Test of gene significance: CASPR uses SAMtools (Li et al., 2009) to 
convert the BAM files containing mapped reads into a count table, which 
is taken as input to perform the assessment of gene significance. PBNPA 
(Jia et al., 2017) and MAGeCK in the adjusted Robust Rank Aggregation 
mode —α-RRA(Li et al., 2014) are employed in parallel. The degree of 
agreement between the two methods may be inspected with Venn dia-
grams. The raw gene-level P-values of PBNPA and MAGeCK are com-
bined into a consensus value by Fisher’s method (Fisher, 1970). Finally, 
P-values are adjusted to a false discovery rate (FDR) by the Benjamini-
Hochberg method. To aid visualisation of results, CASPR generates mul-
tiple plots in R —quantile-quantile plots, volcano plots, box-plots, and 
other scatter plots. It also creates configuration files that can be inspected 
using VISPR, the web-based interactive framework (Li et al., 2015). 
 
Software and versions: CASPR was tested with STAR 2.6.0c, FastQC 
v0.11.8, cutadapt 1.18, FASTX-Toolkit 0.0.14, SAMtools 1.4.1, 
MAGeCK 0.5.8, R 3.5.0, PBNPA 0.0.3 and VISPR 0.4.14. 
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Data and accession codes 
All analyses were based on GENCODE 19 gene annotations, and any 
other genes were discarded. Analyses presented here are based on two 
published lncRNA CRISPR screens: the CRISPRi study by Liu et al (Liu 
et al., 2017) and the CRISPR-del study by Zhu et al (Zhu et al., 2016). 
From these studies we extracted the subset of gene targets that belong to 
GENCODE annotations, leaving 4,325 lncRNAs and 666 lncRNAs for 
the CRISPRi and CRISPR-del screens, respectively. The names of genes 
targeted by each study were obtained from the original publication, then 
converted to GENCODE identifiers using BioMart-ENSEMBL (Smedley 
et al., 2015). For consistency and to allow fair comparisons of the 
CRISPR-del and CRISPRi studies, human genome assembly 
hg19/GRCh37 was used in analyses requiring gene coordinates. RNA-
sequencing expression data was obtained from ENCODE, under acces-
sion codes ENCSR000CPR (HeLa), ENCSR000CPT (MCF7) and 
ENCSR000BYO (U87). Cell lines and lncRNAs for which data was not 
available were omitted. Coordinates of FANTOM5 peaks were retrieved 
from FANTOM database (FANTOM Consortium and the RIKEN PMI 
and CLST (DGT) et al., 2014), considering the ‘robust’ CAGE peaks in 
hg19 coordinates. Studies of transcription start site annotation were not 
performed with the CRISPR-del dataset, because it was designed to target 
multiple genomic regions (e.g. introns, exons, promoters and whole 
genes), and not only TSSs. The entire set of CASPR results across all 
cells, perturbations and algorithms are provided in Supplementary File S1. 
  
Benchmark dataset 
As a ground truth dataset for lncRNAs regulating cancer cell growth, we 
used an updated version of the manually curated Cancer LncRNA Census 
(Carlevaro-Fita et al., 2019), and the MiTranscriptome set of tumor-
dysregulated lncRNAs (Iyer et al., 2015). Throughout the paper, we refer 
to these as functionally validated (FV) and differentially-expressed (DE) 
datasets, respectively. FV genes are defined as those with experimental or 
genetic evidence for a causative role in tumorigenesis, and were collected 
through careful manual curation from the scientific literature up to 2018. 
This dataset will be published shortly (Vancura et al, manuscript in prep-
aration). DE is based on gene expression analyses of human transcripts 
from diverse cancer types, and contains significantly differentially-ex-
pressed lncRNAs between tumour and normal samples in at least one can-
cer type. Although an absolute ground-truth is lacking for lncRNAs, FV 
and DE are currently the most reliable set of positive control cancer 
lncRNAs available. For the analyses, only the subset of GENCODE-
annotated lncRNAs are considered. FV comprises a total of 387 lncRNAs 
(Figure 2A), of which 206 and 79 overlap genes screened in CRISPRi and 
CRISPR-del, respectively. Equivalent numbers for DE are 496, 266 and 
86 lncRNAs. 
3 Results 
3.1 CASPR: versatile CRISPR screen analysis 
In order to study lncRNA CRISPR screens, we developed a pipeline called 
CRISPR Analysis for Single and Paired RNA-guides, or CASPR (Figure 
1C). CASPR has several desirable features. Firstly, it is compatible with 
the two principal types of CRISPR screen, namely single-end sequencing 
of single sgRNAs (such as in CRISPRi screens) (Figure 1A), and paired-
end sequencing of paired sgRNAs (CRISPR-del screens, Figure 1C). Sec-
ond, CASPR balances the sensitivity and specificity of predictions, by 
generating a consensus significance estimate from leading yet methodo-
logically-distinct methods MAGeCK and PBNPA (Li et al., 2014; Jia et 
al., 2017). Third, CASPR offers an end-to-end analysis, commencing with 
raw amplicon sequencing reads and delivering finished analyses and pub-
lication-ready plots. All analyses are accompanied by comprehensive 
quality-control analysis and statistics. 
 
3.2 Improved functional maps of lncRNAs in human cells  
We evaluated the performance of CASPR by reanalysing the principal 
loss-of-function (LOF) lncRNA CRISPR screens published to date. The 
Liu study (Liu et al., 2017) utilised CRISPRi with single sgRNAs to 
knock down 16,401 lncRNAs across seven cell lines. The Zhu study uti-
lised CRISPR-del with paired sgRNAs to target different genomic regions 
(e.g introns, exons, promoters and whole genes) of around 700 lncRNAs 
in two cell lines (Zhu et al., 2016). Both studies screened HeLa cells, 
where 281 lncRNAs were targeted in common. 
  
We compared the performance of CASPR’s two integrated hit-identifica-
tion algorithms, MAGeCK and PBNPA. MAGeCK employs a negative 
binomial statistical model to identify significantly enriched or depleted 
targets, while PBNPA utilises an empirical model. The two methods iden-
tify significantly overlapping but distinct sets of hits (Figure 2B). 
  
To fairly evaluate screen performance, we used a benchmark dataset of 
high-confidence cancer lncRNAs, by combining a manually-curated set 
of lncRNAs with functionally-validated roles in cancer (FV), with a set of 
lncRNAs differentially expressed in tumours (DE) (see Methods). In pre-
vious screens, MAGeCK has tended to be run with very permissive false 
discovery rate cutoffs, suggesting it has a stringent behaviour (Zhu et al., 
2016; Gasperini et al., 2017). Indeed, when run at default settings on 
CRISPRi data, it showed high precision but low sensitivity (lighter panels 
in Figure 2C). PBNPA exhibited similar performance, yet with high vari-
ability between cell lines (Figure 2B). Worryingly, both tools identified 
almost no hits in the CRISPR-del data for either cell type (darker panels 
in Figure 2C,D). Values of performance across cell lines are provided in 
Supplementary File S2. 
  
We hypothesised that this relatively poor performance of individual meth-
ods might be mitigated by integrating the predictions of both. Thus raw 
P-values were merged by the Fisher method to yield a consensus signifi-
cance estimate (Fisher, 1970). For the CRISPRi screens, this resulted in 
improved sensitivity, with only a slight reduction in precision as com-
pared to MAGeCK (Figure 2C). More importantly, the consensus method 
identified hits for the CRISPR-del data with acceptable precision, where 
far fewer were observed by either of the two algorithms alone (Figure 
2C,D). Thanks to its improved sensitivity, the consensus approach yields 
an increased number of hits over the individual methods across all cell 
lines and perturbations (Figure 2D). As expected, the consensus method 
produced lncRNA hits with significantly enriched and depleted sgRNAs 
(Figure 2E).  
 
Figure 2. A. Two benchmark sets of cancer-associated genes were compiled from the literature (see Methods). Numbers indicate only GENCODE-annotated lncRNA gene loci. B. Overlap 
of hits identified by MAGeCK and PBNPA algorithms in HeLa CRISPRi screen. C. Sensitivity and precision of MAGeCK, PBNPA and their Fisher consensus, as measured across cell 
types and perturbations. Accuracy is measured with respect to the union of the benchmark gene sets. The consensus measure shows the highest sensitivity, while maintaining relatively stable 
precision across conditions. D. Numbers of hits identified by MAGeCK, PBNPA and consensus, separated by cell line and perturbation. E. Volcano-plot showing the non-hits (gray) and 
hits (blue) based on the consensus method in HeLa CRISPRi screen. Log-fold changes of each gene, obtained from the log-fold changes of all sgRNAs, are shown in the x-axis; statistical 
significance is shown on the y-axis. 
We next compared CASPR to the state-of-the-art in CRISPR screen anal-
ysis, CB2. CB2 has been shown to outcompete many existing methods 
(Jeong et al., 2019). Using CB2, we reanalyzed the CRISPRi screen in 
MCF7 and U87, which were the cell lines with the lowest and highest 
performance of CASPR, respectively. In both screens, a greater number 
of hits were identified by CASPR compared to CB2, and CB2 hits were 
essentially a subset of CASPR hits (Supplementary Figure S1 A-C). Im-
portantly, CB2 provided a higher precision at the cost of reducing the sen-
sitivity, and the AUC was always lower (Supplementary Figure S1 E-F). 
It is important to note that performance estimates based on ROC curve are 
likely to be underestimates, since our benchmarking data is incomplete 
and many true positives are likely to be interpreted here as false positives.  
 
We also tested the performance of CASPR on CRISPR growth screens of 
protein-coding genes. Taking known essential and non-essential genes as 
the benchmark, we evaluated performance of CASPR and CB2 on two 
screens: a conventional CRISPR mutation and a CRISPRi screen in 
RT112 cells (Evers et al., 2016). For CASPR at an FDR <0.01, precision 
is 100% / 100% and sensitivity is 52% / 26%, respectively, while optimal 
performance in each was achieved at FDR < 0.75 / 0.13, respectively. The 
overall performance of CASPR is slightly below that of CB2 (Supplemen-
tary Figure S1 G-H), indicating that CASPR can be used for analysis of 
protein-coding gene screens. 
 
Thus, CASPR provides an improved sensitivity performance in the anal-
ysis of lncRNA CRISPR screens. For the rest of the paper, we use CASPR 
hits at a FDR cutoff of < 0.01. 
3.3 Comparing performance of CRISPRi and CRISPR-del 
We next sought to compare the performance of the two loss-of-function 
perturbations, CRISPRi and CRISPR-del. It should be noted that data 
comes from distinct publications, targeting different (but partially over-
lapping) sets of lncRNAs. 
 
First, we compared the hits in common between the two methods in the 
shared cell line, HeLa. Surprisingly, when only considering lncRNAs tar-
geted in both experiments, one observes zero overlap in the hits. These 
differences are underlined by the fact that no correlation is observed in 
screening results (Figure 3A). 
Figure 3. A. Pearson’s correlation between CRISPRi and CRISPR-del FDR in HeLa. B, C. Overlap of consensus hits with benchmark datasets. CRISPRi hits (light gray) show a significant 
overlap with experimentally-validated (light green) and differentially-expressed (dark green) lncRNA sets, while CRISPR-del hits (dark gray) show a weaker and non-significant overlap 
with both sets. D, E. Precision of CASPR consensus method with increasing FDR threshold, for each cell line. Dashed lines indicate the expected background precision. 
We used our benchmark dataset to evaluate the performance of CRISPRi 
and CRISPR-del across studied cell lines. For CRISPRi, the union of hits 
is significantly enriched in both functionally-validated lncRNAs and dif-
ferentially-expressed lncRNAs (Figure 3B). In contrast, the union of 
CRISPR-del hits are significantly enriched in neither (Figure 3C). It 
should be noted that the lower number of CRISPR-del hits is likely to 
impact statistical power. 
 
We further evaluated performance by calculating the precision in identi-
fying cancer lncRNAs, as a function of increasing FDR (Figure 3D,E). 
Note that precision should be compared to the overall frequency of cancer 
lncRNAs amongst the screen targets (shown as dotted lines). In the CRIS-
PRi study, the expected behaviour is observed: high precision at low FDR, 
decreasing as FDR threshold is increased (Figure 3D). This trend holds 
for all cell lines, although MCF7 cells show comparatively weak perfor-
mance. For CRISPR-del, one observes moderate precision at low FDR for 
Huh7.5 cells, but this tapers off rapidly with increasing FDR cutoff (Fig-
ure 3D). In contrast, hits in HeLa are depleted for cancer lncRNAs com-
pared to background expectation (Figure 3D). Receiver-operator curves 
(Supplementary Figure S2 A-F) support these observations, although the 
incompleteness of the benchmarking dataset likely leads to underesti-
mates of the areas under the curves (AUC). 
 
Overall, these data show that CRISPRi screens are generally capable of 
identifying bona fide cancer lncRNAs, while the two available CRISPR-
del screens display weaker and more variable performance.  
3.4 Parameters correlating with success of CRISPR screens 
Factors correlating with phenotypic hits in CRISPR screens could be used 
in future to optimise screen design. Liu et al showed that target gene ex-
pression is the single factor with greatest predictive power for identifying 
hits (Liu et al., 2017). We tested this in the CRISPRi data for cells where 
ENCODE public RNA-sequencing data is also available. In agreement, 
we found that on average, lncRNA hits have between 3 to 6-fold greater 
expression than non-hits in CRISPRi data (lighter panels in Figure 4A). 
A different behaviour was observed for CRISPR-del screen in HeLa, in 
which no significant difference is observed in the expression between hits 
and non-hits, again suggesting that this screen produced few true positives 
(darker panels in Figure 4A). 
 
For effective perturbation, sgRNAs must be recruited within a narrow ge-
nomic window around the target’s transcription start site (TSS) (Sanson 
et al., 2018). The accuracy of present lncRNA transcript annotations is 
rather poor, and a large fraction of annotated transcript 5’ ends probably 
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Figure 4.  A. Gene expression levels between consensus screen hits (blue) and non-hits (orange). Expression is measured by RNA-sequencing from the ENCODE consortium. B. The 
distance from targeted transcription start site (TSS) to the true TSS, the latter inferred from CAGE peaks mapped by the FANTOM consortium. C, D, E. Selection criteria for lncRNA 
inclusion future screens. Each cell holds the hit rate (percent of screened lncRNAs that are a hit, as defined by consensus method). Axes indicate increasing thresholds for gene expression 
(y-axis) and distance from targeted TSS to nearest CAGE peaks (x-axis). High hit rates (blue) are identified at high expression levels and low distances.
lie kilobases or more from the true TSS (Uszczynska-Ratajczak et al., 
2018). Thus, we hypothesised that lncRNA hits should have annotated 
start sites closer to true TSS, compared to non-hits. 
 
To test this, we compared the start position of lncRNA annotations to map 
of true TSS, as defined by Cap Analysis of Gene Expression (CAGE) 
(FANTOM Consortium and the RIKEN PMI and CLST (DGT) et al., 
2014). We observed that the average hit’s annotated TSS is within 100 bp 
of a CAGE peak, whereas average non-hits are >1 kb away (Figure 4B). 
This is observed in all CRISPRi experiments. For CRISPR-del screens, 
these analyses were not feasible, due to the mixture of TSS and whole-
gene targeting. 
 
We considered the possibility of a confounding interaction between gene  
expression and CAGE peak presence. However, linear models trained 
with CAGE peak distance and gene expression showed that interaction 
was not significant, while each factor individually contributed to the prob-
ability of being a screen hit (P-values are shown in Figure 4A,B). 
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To facilitate future screen designs, we integrated the above insights into a 
scheme for target selection (Figure 4C-E). For given thresholds of anno-
tated TSS to CAGE distance (x-axis) and expression (y-axis), one can look 
up the hit rates in each cell-line. In HeLa (Figure 4C), hit rates range from 
a baseline of 2.3% with no filtering, to around 8% when only considering 
lncRNAs with TSS <100 bp from a CAGE peak and expression >2 
FPKM. Similar trends were observed for other cell lines, considering only 
lncRNAs annotated in GENCODE and for which expression data was 
available. These values should be a useful guide in the selection of targets 
for future lncRNA screens. 
4 Discussion 
Here we have presented CASPR, a pipeline for CRISPR screen analysis 
that is characterised by being an end-to-end solution that can equally han-
dle single or paired sgRNA datasets, and balances sensitivity and specific-
ity through consensus prediction from two leading algorithms. We antici-
pate that CASPR will be useful for the growing number of groups world-
wide who are applying CRISPR functional screening to lncRNAs and 
other noncoding genomic elements including enhancers (Gasperini et al., 
2017; Diao et al., 2017). 
 
In terms of performance, CASPR displays improved sensitivity compared 
to leading methods MAGeCK and PBNPA, while maintaining similar 
specificity. Critically, CASPR maintains competitive performance in both 
single (CRISPRi) and paired (CRISPR-del) sgRNA experiments, com-
pared to either algorithm alone. Thus CASPR is suitable for both main 
CRISPR screen types. CASPR has been mainly designed and applied to 
study lncRNA datasets, but it also performs well on CRISPR screens of 
protein-coding genes with either mutation or CRISPRi perturbations. 
 
The growing interest in CRISPR screening highlights the need for library 
design guidelines. This is particularly challenging for lncRNAs, due to our 
ignorance of which ones are functional, and the incomplete state of their 
gene annotations (Kopp and Mendell, 2018; Uszczynska-Ratajczak et al., 
2018). Previous work suggested that steady-state RNA levels were a use-
ful guide to predicting lncRNA hits in CRISPRi screens (Liu et al., 2017). 
We have corroborated this, and identified a new criterion for target selec-
tion in the form of transcription start site (TSS) annotations. Combining 
these two measures, we have produced guidelines for selection of 
lncRNAs for inclusion in CRISPR libraries. These guidelines should im-
prove future projects by enabling researchers to create smaller libraries 
focussed on more promising lncRNAs. 
 
We also evaluated the performance of the small number of available 
CRISPR screens. Overall, CRISPRi data from Liu et al contained a large 
and statistically-significant number of previously-identified benchmark 
gene sets of cancer-promoting or cancer-related lncRNAs. Furthermore, 
CRISPRi hits tend to be higher expressed and have well-annotated TSS. 
Altogether, this highlights the quality of the Liu data and the power of 
CRISPRi in identifying functional lncRNAs. On the other hand, the 
CRISPR-del data, at least for HeLa cells that could be compared to CRIS-
PRi and for which RNA-seq data were available, displayed no enrichment 
for known cancer-lncRNAs, suggesting that this experiment yielded few 
genuine hits. It is possible that this low sensitivity arises, in part, due to 
the fact that in many cases, entire lncRNA genes were targeted, in contrast 
to their TSS alone. It is likely that these relatively large deletions are less 
efficient (Canver et al., 2014). Other studies have demonstrated the effi-
cacy of CRISPR-del as a perturbation strategy (Ho et al., 2015; Aparicio-
Prat et al., 2015), although a recent study and our own unpublished work, 
suggests that promoter deletions may give rise to unexpected gene pertur-
bations (Lavalou et al., 2019). At any rate, the Huh7.5 CRISPR-del screen 
did appear to make true positive predictions. In summary, these findings 
show that both CRISPRi and CRISPR-del are effective perturbations for 
pooled screening approaches, although more CRISPR-del data will be 
necessary to properly compare the performance of these two methods. 
 
Finally, these results support the existence of bona fide functional 
lncRNAs that regulate cell growth, a fundamental cellular phenotype. The 
fact that CRISPRi screen hits significantly overlap two independently-
generated sets of cancer-lncRNAs, suggest that significant numbers of 
functional lncRNAs exist and may be found by CRISPR-based strategies. 
 
In summary, CASPR will be a useful tool for researchers wishing to em-
ploy CRISPR screening to map the functional elements within the non-
coding genome. 
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